JP2005538932A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005538932A5 JP2005538932A5 JP2003566175A JP2003566175A JP2005538932A5 JP 2005538932 A5 JP2005538932 A5 JP 2005538932A5 JP 2003566175 A JP2003566175 A JP 2003566175A JP 2003566175 A JP2003566175 A JP 2003566175A JP 2005538932 A5 JP2005538932 A5 JP 2005538932A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- variant
- albumin
- fusion protein
- albumin fusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000009027 Albumins Human genes 0.000 claims 47
- 108010088751 Albumins Proteins 0.000 claims 47
- 239000012634 fragment Substances 0.000 claims 47
- 108020001507 fusion proteins Proteins 0.000 claims 27
- 102000037865 fusion proteins Human genes 0.000 claims 27
- 108090000765 processed proteins & peptides Proteins 0.000 claims 21
- 238000001727 in vivo Methods 0.000 claims 13
- 238000000034 method Methods 0.000 claims 12
- 210000004027 cell Anatomy 0.000 claims 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 230000004071 biological effect Effects 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000035475 disorder Diseases 0.000 claims 4
- 230000002950 deficient Effects 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 201000003883 Cystic fibrosis Diseases 0.000 claims 2
- 206010019860 Hereditary angioedema Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 2
- 102000012479 Serine Proteases Human genes 0.000 claims 2
- 108010022999 Serine Proteases Proteins 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 230000004927 fusion Effects 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 108010088842 Fibrinolysin Proteins 0.000 claims 1
- 208000032843 Hemorrhage Diseases 0.000 claims 1
- 101000851058 Homo sapiens Neutrophil elastase Proteins 0.000 claims 1
- 102000001399 Kallikrein Human genes 0.000 claims 1
- 108060005987 Kallikrein Proteins 0.000 claims 1
- 108091005804 Peptidases Proteins 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 claims 1
- 208000034158 bleeding Diseases 0.000 claims 1
- 230000000740 bleeding effect Effects 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000013595 glycosylation Effects 0.000 claims 1
- 238000006206 glycosylation reaction Methods 0.000 claims 1
- 102000052502 human ELANE Human genes 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000004962 physiological condition Effects 0.000 claims 1
- 229940012957 plasmin Drugs 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 238000003860 storage Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35554702P | 2002-02-07 | 2002-02-07 | |
| PCT/US2003/003616 WO2003066824A2 (en) | 2002-02-07 | 2003-02-07 | Albumin-fused kunitz domain peptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009239593A Division JP2010046076A (ja) | 2002-02-07 | 2009-10-16 | アルブミン融合クニッツドメインペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005538932A JP2005538932A (ja) | 2005-12-22 |
| JP2005538932A5 true JP2005538932A5 (enExample) | 2006-03-16 |
Family
ID=27734531
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003565501A Pending JP2005516607A (ja) | 2002-02-07 | 2003-02-07 | Ｈｉｖ阻害タンパク質 |
| JP2003565508A Pending JP2005530484A (ja) | 2002-02-07 | 2003-02-07 | アルブミン融合抗血管形成ペプチド |
| JP2003566175A Pending JP2005538932A (ja) | 2002-02-07 | 2003-02-07 | アルブミン融合クニッツドメインペプチド |
| JP2009239593A Pending JP2010046076A (ja) | 2002-02-07 | 2009-10-16 | アルブミン融合クニッツドメインペプチド |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003565501A Pending JP2005516607A (ja) | 2002-02-07 | 2003-02-07 | Ｈｉｖ阻害タンパク質 |
| JP2003565508A Pending JP2005530484A (ja) | 2002-02-07 | 2003-02-07 | アルブミン融合抗血管形成ペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009239593A Pending JP2010046076A (ja) | 2002-02-07 | 2009-10-16 | アルブミン融合クニッツドメインペプチド |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US20060122374A1 (enExample) |
| EP (4) | EP1471928A1 (enExample) |
| JP (4) | JP2005516607A (enExample) |
| KR (4) | KR20110014661A (enExample) |
| CN (3) | CN1646154B (enExample) |
| AU (5) | AU2003244515A1 (enExample) |
| CA (3) | CA2475382A1 (enExample) |
| NZ (3) | NZ579419A (enExample) |
| WO (3) | WO2003066085A1 (enExample) |
| ZA (3) | ZA200406124B (enExample) |
Families Citing this family (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1489097E (pt) | 1994-01-11 | 2012-01-04 | Dyax Corp | Inibidores de plasmina humana derivados de domínios kunitz e ácidos nucleicos codificando os mesmos |
| US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
| CA2488558C (en) | 2002-06-07 | 2013-08-20 | Dyax Corp. | Prevention and reduction of blood loss |
| GB0217033D0 (en) * | 2002-07-23 | 2002-08-28 | Delta Biotechnology Ltd | Gene and polypeptide sequences |
| ES2709103T3 (es) * | 2002-08-28 | 2019-04-15 | Dyax Corp | Métodos para conservar órganos y tejidos |
| CA2507904C (en) | 2002-12-19 | 2014-12-02 | M. Elizabeth Snell | Cyanovirin variant-polymer conjugates |
| EP1594530A4 (en) * | 2003-01-22 | 2006-10-11 | Human Genome Sciences Inc | HYBRID PROTEINS OF ALBUMIN |
| US6989369B2 (en) | 2003-02-07 | 2006-01-24 | Dyax Corp. | Kunitz domain peptides |
| CA2537236A1 (en) * | 2003-08-29 | 2005-05-12 | Children's Medical Center Corporation | Anti-angiogenic peptides for treating or preventing endometriosis |
| US7524811B2 (en) * | 2003-08-29 | 2009-04-28 | Children's Medical Center Corporation | Anti-angiogenic peptides from the N-terminus of endostatin |
| GB0329681D0 (en) | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Gene expression technique |
| AU2004308952A1 (en) * | 2003-12-23 | 2005-07-14 | Centocor, Inc. | Anti-retroviral agents, compositions, methods and uses |
| GB0329722D0 (en) | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Modified plasmid and use thereof |
| TW200607523A (en) | 2004-06-01 | 2006-03-01 | Domantis Ltd | Drug compositions, fusions and conjugates |
| AU2011218732B2 (en) * | 2004-09-27 | 2013-07-04 | Takeda Pharmaceutical Company Limited | Kallikrein Inhibitors and Uses Thereof |
| US7235530B2 (en) * | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| ES2325344B1 (es) * | 2004-11-02 | 2010-06-09 | Univ Madrid Autonoma | Inhibidores de angiogenesis multifuncionales y multivalentes. |
| WO2006057997A2 (en) * | 2004-11-22 | 2006-06-01 | Dyax Corp. | Plasmin-inhibitory therapies |
| JP5631533B2 (ja) | 2004-12-23 | 2014-11-26 | ノボザイムス バイオファーマ デーコー アクティーゼルスカブ | 遺伝子発現技術 |
| PT1981519T (pt) * | 2005-12-29 | 2018-02-23 | Dyax Corp | Inibição de protéases |
| CN100475270C (zh) * | 2006-01-20 | 2009-04-08 | 清华大学 | 一种治疗肿瘤的药物及其应用 |
| EP1816201A1 (en) * | 2006-02-06 | 2007-08-08 | CSL Behring GmbH | Modified coagulation factor VIIa with extended half-life |
| HUE039108T2 (hu) | 2006-03-16 | 2018-12-28 | Dyax Corp | Készítmények és eljárások szembetegségek kezelésére |
| CA3161849A1 (en) | 2007-01-30 | 2008-08-07 | Epivax, Inc. | Regulatory t cell epitopes, compositions and uses thereof |
| AR067584A1 (es) * | 2007-07-20 | 2009-10-14 | Hoffmann La Roche | Un conjugado de un anticuerpo contra la cd4 y peptidos antifusogenicos |
| EP2201036A1 (en) | 2007-08-08 | 2010-06-30 | Novozymes Biopharma DK A/S | Transferrin variants and conjugates |
| CA2695012A1 (en) * | 2007-08-23 | 2009-02-26 | Genzyme Corporation | Treatment with kallikrein inhibitors |
| US9025330B2 (en) | 2007-09-30 | 2015-05-05 | Alcatel Lucent | Recirculating gas rack cooling architecture |
| EP2353010B1 (en) | 2008-10-28 | 2015-07-08 | Uladzimir A. Murauski | Methods for detection of toxemia |
| US8637454B2 (en) | 2009-01-06 | 2014-01-28 | Dyax Corp. | Treatment of mucositis with kallikrein inhibitors |
| SG172789A1 (en) | 2009-02-11 | 2011-08-29 | Novozymes Biopharma Dk As | Albumin variants and conjugates |
| EP2427486B1 (en) | 2009-05-07 | 2015-02-25 | Novozymes Biopharma DK A/S | Method for purifying albumin |
| BR112012009450A2 (pt) | 2009-10-30 | 2017-05-23 | Novozymes Biopharma Dk As | variantes de albumina |
| RS62853B1 (sr) | 2010-01-06 | 2022-02-28 | Takeda Pharmaceuticals Co | Proteini koji vezuju kalikrein plazme |
| CN101875693B (zh) * | 2010-01-22 | 2012-07-18 | 成都正能生物技术有限责任公司 | 具备抗血管生成活性的白蛋白变异体及其制备方法 |
| EP2556087A1 (en) * | 2010-04-09 | 2013-02-13 | Novozymes Biopharma DK A/S | Albumin derivatives and variants |
| EP2616487B1 (en) * | 2010-09-14 | 2015-03-25 | F.Hoffmann-La Roche Ag | Serpin-finger fusion polypeptide |
| CN102453097A (zh) * | 2010-10-27 | 2012-05-16 | 上海科新生物技术股份有限公司 | 抑制血管新生的融合蛋白vf及药物组合物和应用 |
| EP2635598A1 (en) | 2010-11-01 | 2013-09-11 | Novozymes Biopharma DK A/S | Albumin variants |
| AU2012204202A1 (en) | 2011-01-06 | 2013-07-11 | Dyax Corp. | Plasma kallikrein binding proteins |
| AU2012251583B2 (en) | 2011-05-05 | 2017-06-08 | Albumedix Ltd. | Albumin variants |
| ES2659161T3 (es) * | 2011-08-17 | 2018-03-14 | The Regents Of The University Of Colorado, A Body Corporate | Proteína de fusión de transferrina-tumstatina y métodos para producir y usar la misma |
| CN102532326B (zh) * | 2011-11-18 | 2017-06-09 | 南京大学 | 一种肿瘤靶向的人纤溶酶原Kringle5变体及其应用 |
| EP2780364A2 (en) | 2011-11-18 | 2014-09-24 | Eleven Biotherapeutics, Inc. | Proteins with improved half-life and other properties |
| WO2013124325A1 (en) | 2012-02-20 | 2013-08-29 | Murauski Uladzimir A | Methods and kits for detection of active malignancy |
| ES2664328T3 (es) | 2012-03-16 | 2018-04-19 | Albumedix A/S | Variantes de albúmina |
| JP2015528454A (ja) * | 2012-08-28 | 2015-09-28 | ノバルティス アーゲー | 眼血管増殖性疾患の処置におけるｖｅｇｆアンタゴニストの使用 |
| CA2890766A1 (en) | 2012-11-08 | 2014-05-15 | Novozymes Biopharma Dk A/S | Albumin variants |
| HRP20190528T1 (hr) * | 2013-01-20 | 2019-05-17 | Dyax Corp. | PROCJENA, TESTOVI I LIJEČENJE POREMEĆAJA POSREDOVANIH S pKAL |
| KR20150118123A (ko) | 2013-02-16 | 2015-10-21 | 노보자임스 바이오파마 디케이 에이/에스 | 약동학적 동물 모델 |
| WO2014182684A2 (en) * | 2013-05-06 | 2014-11-13 | Cell Machines, Inc. | Methods and compositions related to large scale production of proteins |
| CN103333255A (zh) * | 2013-06-28 | 2013-10-02 | 复旦大学 | 一种长效hiv‐1膜融合抑制剂 |
| AU2015235967B2 (en) | 2014-03-27 | 2020-10-22 | Takeda Pharmaceutical Company Limited | Compositions and methods for treatment of diabetic macular edema |
| DE102014112212A1 (de) | 2014-08-26 | 2016-03-03 | Akesion Gmbh | Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen |
| CN105440138A (zh) * | 2014-09-30 | 2016-03-30 | 复旦大学 | 一种长效内皮抑素融合蛋白的制备方法和用途 |
| EP3303421A4 (en) * | 2015-05-30 | 2019-03-27 | Genomatica, Inc. | VINYL ISOMERASEDEHYDRATASES, ALKENOLDEHYDRATASES, LINALOOLDEHYDRATASES AND CROTYL ALCOHOL DEHYDRATASES AND METHOD FOR THE PRODUCTION AND USE THEREOF |
| CN104926946B (zh) * | 2015-07-13 | 2021-09-17 | 中国科学院广州生物医药与健康研究院 | 具有延长体内半衰期的adamts13-mdtcs融合蛋白及其应用 |
| CA2989966C (en) | 2015-08-20 | 2024-04-30 | Albumedix A/S | Albumin variants and conjugates |
| HRP20210635T1 (hr) * | 2015-09-08 | 2021-08-20 | Jcr Pharmaceuticals Co., Ltd. | Novi mutant humanog seruma albumina |
| CN110498851B (zh) * | 2015-11-10 | 2022-10-11 | 孙嘉琳 | 一种抗肿瘤蛋白内皮抑素的衍生物及应用 |
| CN116077648A (zh) | 2015-12-11 | 2023-05-09 | 武田药品工业株式会社 | 血浆激肽释放酶抑制剂及其治疗遗传性血管性水肿发作的用途 |
| JP7146637B2 (ja) | 2015-12-22 | 2022-10-04 | アルブミディクス リミティド | 改善されたタンパク質発現株 |
| CN108431204A (zh) | 2015-12-22 | 2018-08-21 | 阿尔布梅迪克斯医疗有限公司 | 改良的表达蛋白质的菌株 |
| CN105646717B (zh) * | 2016-01-26 | 2020-06-09 | 复旦大学 | 一种长效hiv融合抑制剂及其应用 |
| CA3064037A1 (en) | 2017-06-20 | 2018-12-27 | Albumedix Ltd | Improved protein expression strains |
| WO2019032472A1 (en) * | 2017-08-08 | 2019-02-14 | The Board Of Trustees Of The Leland Stanford Junior University | HIGH AFFINITY MODIFIED MATRIX INHIBITOR |
| AU2018326835A1 (en) * | 2017-08-31 | 2020-03-26 | National University Of Singapore | Angio-3 for treatment of retinal angiogenic diseases |
| US20190092818A1 (en) * | 2017-09-22 | 2019-03-28 | Kite Pharma, Inc. | Chimeric polypeptides and uses thereof |
| PL3684786T3 (pl) * | 2017-09-22 | 2024-12-16 | Centre National De La Recherche Scientifique (Cnrs) | Zmutowana glikoproteina wirusa pęcherzykowego zapalenia jamy ustnej |
| BR112021008200A2 (pt) | 2018-10-29 | 2021-12-14 | Spin Therapeutics Llc | Composições e métodos para distúrbios de alfa-1-antitripsina |
| DE102019000490A1 (de) * | 2019-01-23 | 2020-07-23 | HAEMES Verwaltungsgesellschaft mbH | Verwendung von Oligonukleotiden für die Behandlung von Tumoren |
| JP7531518B2 (ja) | 2019-04-16 | 2024-08-09 | 武田薬品工業株式会社 | 機能的なＣ１エステラーゼインヒビター（ｆＣ１－ＩＮＨ）の定量化のための方法 |
| CN111995686B (zh) * | 2019-05-27 | 2022-06-14 | 兰州大学 | 一种具有抗血管生成活性的药物及其制备方法 |
| MX2022008649A (es) | 2020-01-13 | 2022-09-23 | Takeda Pharmaceuticals Co | Inhibidores de calicreina plasmatica y sus usos para tratar episodios de angioedema hereditario pediatrico. |
| CN111494604B (zh) * | 2020-05-11 | 2022-05-06 | 中国药科大学 | 蓝藻抗病毒蛋白n在制备抗炎药物中的应用 |
| CN111560049B (zh) * | 2020-05-17 | 2022-05-17 | 浙江大学 | 两性离子多肽及其衍生物以及以其为基础的纳米药物 |
| EP4186928A4 (en) * | 2020-07-08 | 2024-10-09 | Nanjing Normal University | Fusion polypeptide and polypeptide dimer, and use thereof |
| KR20260011663A (ko) * | 2023-03-28 | 2026-01-23 | 가부시키가이샤 에누비 켄코우겡큐쇼 | 항체, 핵산, 세포 및 의약 |
| EP4442251A1 (en) | 2023-04-05 | 2024-10-09 | Albumedix Ltd | Formulations and uses thereof |
| US12440564B2 (en) | 2023-09-25 | 2025-10-14 | Kelonia Therapeutics, Inc. | Compositions for treating cancer |
| CN117924430B (zh) * | 2024-03-22 | 2024-06-28 | 中国人民解放军军事科学院军事医学研究院 | 促进血小板生成的tpor结合肽 |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US355547A (en) | 1887-01-04 | mebcee | ||
| CA91311A (en) | 1904-11-15 | 1905-01-31 | The Canadian Westinghouse Company, Limited | Single phase alternating current motors |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4736866A (en) | 1984-06-22 | 1988-04-12 | President And Fellows Of Harvard College | Transgenic non-human mammals |
| DE3668186D1 (de) | 1985-04-01 | 1990-02-15 | Celltech Ltd | Transformierte myeloma-zell-linie und dieselbe verwendendes verfahren zur expression eines gens, das ein eukaryontisches polypeptid kodiert. |
| GB8510219D0 (en) | 1985-04-22 | 1985-05-30 | Bass Plc | Isolation of fermentation products |
| JPS6296086A (ja) | 1985-10-21 | 1987-05-02 | Agency Of Ind Science & Technol | 複合プラスミド |
| US5576195A (en) | 1985-11-01 | 1996-11-19 | Xoma Corporation | Vectors with pectate lyase signal sequence |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| GB8615701D0 (en) | 1986-06-27 | 1986-08-06 | Delta Biotechnology Ltd | Stable gene integration vector |
| US4857467A (en) | 1986-07-23 | 1989-08-15 | Phillips Petroleum Company | Carbon and energy source markers for transformation of strains of the genes Pichia |
| GB8620926D0 (en) | 1986-08-29 | 1986-10-08 | Delta Biotechnology Ltd | Yeast promoter |
| GB2210621B (en) | 1987-04-09 | 1990-11-21 | Delta Biotechnology Ltd | Two micron yeast plasmid vector |
| EP0370050B1 (en) | 1987-07-08 | 1994-05-18 | Primtec | Hold-pressure control and clamping in stacked multi-parting molding system having desynchronized injection periods |
| GB8725529D0 (en) | 1987-10-30 | 1987-12-02 | Delta Biotechnology Ltd | Polypeptides |
| KR100195632B1 (ko) | 1988-07-23 | 1999-06-15 | 스티븐 조지 가랜드 | 펩티드 및 dna 배열 |
| FR2649991B2 (fr) | 1988-08-05 | 1994-03-04 | Rhone Poulenc Sante | Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces |
| US5663143A (en) * | 1988-09-02 | 1997-09-02 | Dyax Corp. | Engineered human-derived kunitz domains that inhibit human neutrophil elastase |
| US5328470A (en) | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| US5766883A (en) * | 1989-04-29 | 1998-06-16 | Delta Biotechnology Limited | Polypeptides |
| GB8924021D0 (en) | 1989-10-25 | 1989-12-13 | Celltech Ltd | Recombinant dna method and vectors for the use therein |
| US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US6270989B1 (en) | 1991-11-05 | 2001-08-07 | Transkaryotic Therapies, Inc. | Protein production and delivery |
| FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US5602307A (en) | 1992-08-12 | 1997-02-11 | Baylor College Of Medicine | Non-human animal having predefined allele of a cellular adhesion gene |
| DE4226971C2 (de) | 1992-08-14 | 1997-01-16 | Widmar Prof Dr Tanner | Modifizierte Pilzzellen und Verfahren zur Herstellung rekombinanter Produkte |
| TW402639B (en) | 1992-12-03 | 2000-08-21 | Transkaryotic Therapies Inc | Protein production and protein delivery |
| US5489743A (en) | 1993-01-19 | 1996-02-06 | Amgen Inc. | Transgenic animal models for thrombocytopenia |
| US5464933A (en) * | 1993-06-07 | 1995-11-07 | Duke University | Synthetic peptide inhibitors of HIV transmission |
| PT739355E (pt) * | 1994-01-11 | 2005-01-31 | Dyax Corp | Proteinas de 'dominio de kunitz' inibidoras de calicreina e seus analogos |
| US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| PT1489097E (pt) * | 1994-01-11 | 2012-01-04 | Dyax Corp | Inibidores de plasmina humana derivados de domínios kunitz e ácidos nucleicos codificando os mesmos |
| GB9404270D0 (en) | 1994-03-05 | 1994-04-20 | Delta Biotechnology Ltd | Yeast strains and modified albumins |
| AU692865B2 (en) * | 1994-04-26 | 1998-06-18 | Children's Medical Center Corporation | Angiostatin and method of use for inhibition of angiogenesis |
| GB9411356D0 (en) | 1994-06-07 | 1994-07-27 | Delta Biotechnology Ltd | Yeast strains |
| US5854205A (en) * | 1995-10-23 | 1998-12-29 | The Children's Medical Center Corporation | Therapeutic antiangiogenic compositions and methods |
| US5854221A (en) * | 1996-12-12 | 1998-12-29 | The Children's Medical Center Corporation | Endothelial cell proliferation inhibitor and method of use |
| GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
| US6797488B1 (en) * | 1997-12-08 | 2004-09-28 | Beth Israel Deaconess Medical Center | Methods of producing anti-angiogenic proteins |
| US6258782B1 (en) * | 1998-05-20 | 2001-07-10 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
| US20030012792A1 (en) * | 1998-05-22 | 2003-01-16 | Holaday John W. | Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using cancer markers |
| US6087473A (en) | 1999-05-26 | 2000-07-11 | Zymogenetics, Inc. | Kunitz domain polypeptide and materials and methods for making it |
| GB9902000D0 (en) | 1999-01-30 | 1999-03-17 | Delta Biotechnology Ltd | Process |
| US20020048571A1 (en) * | 1999-07-19 | 2002-04-25 | Jeno Gyuris | Chimeric polypeptides of serum albumin and uses related thereto |
| US20010056075A1 (en) * | 1999-07-19 | 2001-12-27 | Jeno Gyuris | Chimeric polypeptides of serum albumin and uses related thereto |
| WO2001047958A2 (en) * | 1999-12-29 | 2001-07-05 | Zymogenetics, Inc. | Kunitz domain polypeptide zkun10 |
| AU2001244093A1 (en) | 2000-04-03 | 2001-10-15 | Novozymes A/S | Enzyme tablets for cleaning improvement |
| JP2003530838A (ja) * | 2000-04-12 | 2003-10-21 | ヒューマン ゲノム サイエンシズ インコーポレイテッド | アルブミン融合タンパク質 |
| US6946134B1 (en) * | 2000-04-12 | 2005-09-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| EP1197550A3 (en) * | 2000-08-25 | 2002-11-20 | Pfizer Products Inc. | Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| US20020159992A1 (en) * | 2000-09-29 | 2002-10-31 | Jack Henkin | Antiangiogenic polypeptides and methods for inhibiting angiogenesis |
| ES2425738T3 (es) * | 2001-12-21 | 2013-10-17 | Human Genome Sciences, Inc. | Proteínas de fusión de la albúmina |
| US6989369B2 (en) * | 2003-02-07 | 2006-01-24 | Dyax Corp. | Kunitz domain peptides |
| GB0329681D0 (en) * | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Gene expression technique |
| GB0329722D0 (en) * | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Modified plasmid and use thereof |
| JP5631533B2 (ja) * | 2004-12-23 | 2014-11-26 | ノボザイムス バイオファーマ デーコー アクティーゼルスカブ | 遺伝子発現技術 |
| EP2556087A1 (en) * | 2010-04-09 | 2013-02-13 | Novozymes Biopharma DK A/S | Albumin derivatives and variants |
-
2003
- 2003-02-07 KR KR1020107028953A patent/KR20110014661A/ko not_active Ceased
- 2003-02-07 AU AU2003244515A patent/AU2003244515A1/en not_active Abandoned
- 2003-02-07 JP JP2003565501A patent/JP2005516607A/ja active Pending
- 2003-02-07 ZA ZA200406124A patent/ZA200406124B/xx unknown
- 2003-02-07 WO PCT/IB2003/000433 patent/WO2003066085A1/en not_active Ceased
- 2003-02-07 EP EP03737417A patent/EP1471928A1/en not_active Ceased
- 2003-02-07 CN CN038076411A patent/CN1646154B/zh not_active Expired - Fee Related
- 2003-02-07 CN CNA038075164A patent/CN101166762A/zh active Pending
- 2003-02-07 CN CNA038069687A patent/CN1642567A/zh active Pending
- 2003-02-07 JP JP2003565508A patent/JP2005530484A/ja active Pending
- 2003-02-07 AU AU2003210885A patent/AU2003210885B2/en not_active Ceased
- 2003-02-07 JP JP2003566175A patent/JP2005538932A/ja active Pending
- 2003-02-07 NZ NZ579419A patent/NZ579419A/en not_active IP Right Cessation
- 2003-02-07 NZ NZ534492A patent/NZ534492A/en not_active IP Right Cessation
- 2003-02-07 CA CA002475382A patent/CA2475382A1/en not_active Abandoned
- 2003-02-07 EP EP03737682A patent/EP1572930A4/en not_active Withdrawn
- 2003-02-07 AU AU2003244516A patent/AU2003244516A1/en not_active Abandoned
- 2003-02-07 CA CA002485064A patent/CA2485064A1/en not_active Abandoned
- 2003-02-07 WO PCT/US2003/003616 patent/WO2003066824A2/en not_active Ceased
- 2003-02-07 KR KR10-2004-7012255A patent/KR20040095217A/ko not_active Ceased
- 2003-02-07 KR KR10-2004-7012256A patent/KR20050002823A/ko not_active Ceased
- 2003-02-07 WO PCT/IB2003/000434 patent/WO2003066078A1/en not_active Ceased
- 2003-02-07 KR KR10-2004-7012254A patent/KR20040089608A/ko not_active Ceased
- 2003-02-07 CA CA002475539A patent/CA2475539A1/en not_active Abandoned
- 2003-02-07 US US10/503,836 patent/US20060122374A1/en not_active Abandoned
- 2003-02-07 EP EP09004575A patent/EP2090589A1/en not_active Withdrawn
- 2003-02-07 NZ NZ534310A patent/NZ534310A/en not_active IP Right Cessation
- 2003-02-07 EP EP03737416A patent/EP1471933A1/en not_active Withdrawn
-
2004
- 2004-07-21 ZA ZA200405813A patent/ZA200405813B/en unknown
- 2004-07-21 ZA ZA200405811A patent/ZA200405811B/en unknown
-
2008
- 2008-12-23 AU AU2008264153A patent/AU2008264153A1/en not_active Abandoned
-
2009
- 2009-01-23 US US12/358,815 patent/US20090175893A1/en not_active Abandoned
- 2009-08-27 AU AU2009212820A patent/AU2009212820B2/en not_active Expired - Fee Related
- 2009-10-16 JP JP2009239593A patent/JP2010046076A/ja active Pending
-
2011
- 2011-10-31 US US13/285,727 patent/US20120263747A1/en not_active Abandoned
-
2013
- 2013-07-18 US US13/945,314 patent/US20140017273A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005538932A5 (enExample) | ||
| JP2005530484A5 (enExample) | ||
| CA2667280C (en) | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage | |
| EP3174894B1 (en) | Compositions and methods of use for treating metabolic disorders | |
| ES2279649T3 (es) | Compuestos trombopoyeticos. | |
| CA2529179A1 (en) | Recombinant adeno-associated virus vector for treatment of alzheimer disease | |
| JP2003530839A5 (enExample) | ||
| HUP0203409A2 (hu) | Gamma-interferon-konjugátumok | |
| WO1992007935A1 (en) | Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions | |
| JP7791593B2 (ja) | 細胞透過性ペプチド変異体およびその用途 | |
| JP5345069B2 (ja) | 低出血性抗凝固性融合タンパク質の調製および使用 | |
| EP0543240A1 (en) | Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same | |
| JP2008502323A5 (enExample) | ||
| JP2022533188A (ja) | 非アルコール性脂肪性肝炎の処置 | |
| WO2005095443A1 (ja) | ペプチド改変を利用したドラッグデリバリーシステム | |
| TW555764B (en) | Human bikunin | |
| JPH07119237B2 (ja) | ヒルジン変異体，その製造法及び抗凝血剤 | |
| AU2013234365B2 (en) | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage | |
| JPH0625289A (ja) | 新規ポリペプチド、新規ｄｎａ、医薬組成物およびポリペプチドの製造方法 | |
| RU2008109246A (ru) | Слитые с альбумином белки | |
| AU2016216675A1 (en) | Protease resistant mmutants of stromal cell derived factor-1 in the repair of tissue damage | |
| HK1192845A (en) | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage | |
| HK1192845B (en) | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage | |
| JP2003079381A5 (enExample) |